IPO Boutique keeps apprised of the active pipeline. Currently there are 76 active IPOs in the pipeline as of June 8, 2018. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why “looks may be perceiving” when it comes to the IPO pipeline in this article.
NEW FILINGS
Company: Forty Seven, Inc.
Symbol: FTSV
Description: They are a clinical-stage immuno-oncology company focused on developing novel checkpoint therapies to activate macrophages in the fight against cancer
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Morgan Stanley, Credit Suisse
Co-Manager(s): BTIG, Canaccord Genuity, Oppenheimer & Co.
Filed: 6-1-18
Company: AFG Holdings, Inc.
Symbol: AFGL
Description: They are a leading original equipment manufacturer that designs and manufactures highly-engineered, mission critical equipment and provides complementary consumable products, parts and aftermarket services
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Goldman Sachs, Credit Suisse, Simmons & Company International, Barclays, Citigroup, Evercore ISI, Wells Fargo Securities
Co-Manager(s): Jefferies, Raymond James, Tudor, Pickering, Holt & Co.
Filed: 6-1-18
Company: EverQuote, Inc
Symbol: EVER
Description: They operate the largest online marketplace for insurance shopping in the United States.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): J.P Morgan, BofA Merrill Lynch
Co-Manager(s): Canaccord Genuity, JMP Securities, Needham & Company Oppenheimer & Co., Raymond James, William Blair
Filed: 6-1-18
Company: GoodBulk Ltd.
Symbol: GBLK
Description: They are a leading international owner and operator of dry bulk vessels, and one of the world’s largest owners of Capesize vessels. Prior to this offering, there has been no active trading market for their common shares, although the common shares are listed on the Norwegian Over-The-Counter List (the OTC), an over-the-counter market that is administered and operated by a subsidiary of the Norwegian Securities Dealers Association.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Morgan Stanley, Credit Suisse
Co-Manager(s): Clarksons Platou Securities Evercore ISI, Pareto Securities, UBS Investment Bank, ABN AMRO
Filed: 6-1-18
Company: Translate Bio, Inc.
Symbol: TBIO
Description: They are a leading messenger RNA, or mRNA, therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Citigroup, Leerink Partners, Evercore ISI
Filed: 6-1-18
Company: Domo, Inc.
Symbol: DOMO
Description: Domo is an operating system that powers a business, enabling all employees to access real-time data and insights and take action from their smartphone.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Morgan Stanley, Allen & Company, Credit Suisse, UBS Investment Bank
Co-Manager(s): William Blair, JMP Securities, Cowen
Filed: 6-1-18
Company: Tricida, Inc.
Symbol: TCDA
Description: Their goal is to slow the progression of chronic kidney disease, or CKD, through the treatment of metabolic acidosis.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Goldman Sachs, J.P. Morgan, Cowen
Filed: 6-4-18
Listed Cash Raise: $150m
Company: Cornerstone Management, Inc.
Symbol: CSCA
Description: They are a private equity fund manager in China primarily engaged in the management of private equity funds.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Viewtrade Securities
Filed: 6-5-18
Listed Cash Raise: $70m
TERMS ADDED
Company: Puxin Limited
Symbol: NEW
Description: They are a successful consolidator of the after-school education industry in China.
Trade Date: 6/15
Shares: 7.2 million
Price Range: $17.00-$20.00
Underwriter(s): Citigroup, Deutsche Bank, Barclays, Haitong International, CICC
Terms Added: 6-1-18
Company: Adaptive Insights, Inc.
Symbol: ADIN
Description:
Trade Date: 6/14
Shares: 8.2 million
Price Range: $13.00-$15.00
Underwriter(s): Morgan Stanley, BofA Merrill Lynch, Jefferies, RBC Capital
Co-Manager(s): JMP Securities, Oppenheimer & Co.
Terms Added: 6-4-18
Company: Charah Solutions, Inc.
Symbol: CHRA
Description: They are a leading provider of mission-critical environmental and maintenance services to the power generation industry.
Trade Date: 6/14
Shares: 7.4 million
Price Range: $16.00-$18.00
Underwriter(s): Morgan Stanley, BofA Merrill Lynch, Stifel
Co-Manager(s): Macquarie Capital, First Analysis Securities, Houlihan Lokey
Terms Added: 6-4-18
Company: U.S. Xpress Enterprises, Inc.
Symbol: USX
Description: They are the fifth largest asset-based truckload carrier in the United States by revenue, generating over $1.5 billion in total operating revenue in 2017.
Trade Date: 6/14
Shares: 18.05 million
Price Range: $18.00-$20.00
Underwriter(s): BofA Merrill Lynch, Morgan Stanley, J.P. Morgan, Wells Fargo Securities
Co-Manager(s): Stephens Inc., Stifel, Wolfe Capital Markets
Terms Added: 6-4-18
Company: Avalara, Inc.
Symbol: AVLR
Description: They provide a leading suite of cloud-based solutions designed to improve accuracy and efficiency by automating the processes of determining taxability, identifying applicable tax rates, determining and collecting taxes, preparing and filing returns, remitting taxes, maintaining tax records, and managing compliance documents.
Trade Date: 6/15
Shares: 7.5 million
Price Range: $19.00-$21.00
Underwriter(s): Goldman Sachs & Co., J.P. Morgan, BofA Merrill Lynch
Co-Manager(s): JMP Securities, KeyBanc Capital, Stifel
Terms Added: 6-4-18
Company: Verrica Pharmaceuticals Inc.
Symbol: VRCA
Description: They are a clinical-stage medical dermatology company focused on identifying, developing and commercializing innovative pharmaceutical products for the treatment of skin diseases with significant unmet needs.
Trade Date: 6/15
Shares: 5 million
Price Range: $14.00-$16.00
Underwriter(s): BofA Merrill Lynch, Jefferies, Cowen
Terms Added: 6-5-18
Company: Electrocore, LLC
Symbol: ECOR
Description: They are a commercial-stage bioelectronic medicine company with a platform non-invasive vagus nerve stimulation therapy initially focused on neurology and rheumatology.
Trade Date: 6/22
Shares: 4.33 million
Price Range: $14.00-$16.00
Underwriter(s): Evercore ISI, JMP Securities, BTIG
Terms Added: 6-5-18
Company: Eidos Therapeutics, Inc.
Symbol: EIDX
Description: They are a clinical stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin, or TTR, amyloidosis, or ATTR.
Trade Date: 6/20
Shares: 6.25 million
Price Range: $15.00-$17.00
Underwriter(s): J.P. Morgan, BofA Merrill Lynch
Co-Manager(s): Barclays
Terms Added: 6-8-18
Company: Magenta Therapeutics, Inc.
Symbol: MGTA
Description: They are a clinical-stage biotechnology company developing novel medicines to bring the curative power of bone marrow transplant to more patients.
Trade Date: 6/21
Shares: 6.67 million
Price Range: $14.00-$16.00
Underwriter(s): J.P. Morgan, Goldman Sachs, Cowen
Co-Manager(s): Wedbush PacGrow
Terms Added: 6-8-18
Company: Kezar Life Sciences, Inc.
Symbol: KZR
Description: They are a clinical-stage biotechnology company, discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer.
Trade Date: 6/21
Shares: 4.67 million
Price Range: $14.00-$16.00
Underwriter(s): Jefferies, Cowen, Wells Fargo, William Blair
Terms Added: 6-8-18
Company: Autolus Therapeutics Limited
Symbol: AUTL
Description: They are a biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer.
Trade Date: 6/22
Shares: 7.81 million
Price Range: $15.00-$17.00
Underwriter(s): Goldman Sachs & Co., Jefferies
Co-Manager(s): Wells Fargo Securities, William Blair
Terms Added: 6-8-18
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Portuguese
Russian
Spanish